Digoxin vs Durvalumab

Digoxin vs Durvalumab: Overview

This comparison examines the pharmacological differences between Digoxin and Durvalumab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Durvalumab — Antibody.